Serum cytokeratins determination in differentiated thyroid carcinoma.

@article{Appetecchia2001SerumCD,
  title={Serum cytokeratins determination in differentiated thyroid carcinoma.},
  author={Marialuisa Appetecchia and Aurela Meçule and Marco Ducci and Laura Palma and Mauro Castelli},
  journal={Journal of experimental & clinical cancer research : CR},
  year={2001},
  volume={20 2},
  pages={253-6}
}
To assess the potential value of cytokeratins (CK) 8,18,19 as tumor markers for thyroid diseases, a study was performed comparing serum CK 8,18,19 levels in patients affected from thyroid carcinoma, adenoma, other benign thyroid diseases and healthy volunteers as controls. One hundred cases (65 patients and 35 controls) were examined. Thirty patients had thyroid carcinoma (18 papillary--PTC, 8 follicular--FTC, 4 medullary--MTC), 19 non-toxic goiter, 10 thyroid adenoma, 6 chronic thyroiditis and… CONTINUE READING